ACBD3 Bioinformatic Analysis and Protein Expression in Breast Cancer Cells

<i>ACBD3</i> overexpression has previously been found to correlate with worse prognosis for breast cancer patients and, as an incredibly diverse protein in both function and cellular localisation, ACBD3 may have a larger role in breast cancer than previously thought. This study further i...

Full description

Bibliographic Details
Main Authors: Jack Houghton-Gisby, Rachel Kerslake, Emmanouil Karteris, Kefah Mokbel, Amanda J. Harvey
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/16/8881
_version_ 1797444911454224384
author Jack Houghton-Gisby
Rachel Kerslake
Emmanouil Karteris
Kefah Mokbel
Amanda J. Harvey
author_facet Jack Houghton-Gisby
Rachel Kerslake
Emmanouil Karteris
Kefah Mokbel
Amanda J. Harvey
author_sort Jack Houghton-Gisby
collection DOAJ
description <i>ACBD3</i> overexpression has previously been found to correlate with worse prognosis for breast cancer patients and, as an incredibly diverse protein in both function and cellular localisation, ACBD3 may have a larger role in breast cancer than previously thought. This study further investigated ACBD3′s role in breast cancer. Bioinformatic databases were queried to characterise <i>ACBD3</i> expression and mutation in breast cancer and to investigate how overexpression affects breast cancer patient outcomes. Immunohistochemistry was carried out to examine ACBD3 location within cells and tissue structures. <i>ACBD3</i> was more highly expressed in breast cancer than in any other cancer or matched normal tissue, and expression over the median level resulted in reduced relapse-free, overall, and distant metastasis-free survival for breast cancer patients as a whole, with some differences observed between subtypes. IHC analysis found that ACBD3 levels varied based on hormone receptor status, indicating that ACBD3 could be a candidate biomarker for poor patient prognosis in breast cancer and may possibly be a biomarker for ER signal reprogramming of precancerous breast tissue.
first_indexed 2024-03-09T13:18:16Z
format Article
id doaj.art-3c001331312540a19117c0da174b546f
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T13:18:16Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-3c001331312540a19117c0da174b546f2023-11-30T21:32:34ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-08-012316888110.3390/ijms23168881ACBD3 Bioinformatic Analysis and Protein Expression in Breast Cancer CellsJack Houghton-Gisby0Rachel Kerslake1Emmanouil Karteris2Kefah Mokbel3Amanda J. Harvey4Centre for Genome Engineering and Maintenance, Institute for Health Medicine and Environments, Brunel University London, Uxbridge UB8 3PH, UKCentre for Genome Engineering and Maintenance, Institute for Health Medicine and Environments, Brunel University London, Uxbridge UB8 3PH, UKCentre for Genome Engineering and Maintenance, Institute for Health Medicine and Environments, Brunel University London, Uxbridge UB8 3PH, UKPrincess Grace Hospital, The London Breast Institute, London, W1U 5NY, UKCentre for Genome Engineering and Maintenance, Institute for Health Medicine and Environments, Brunel University London, Uxbridge UB8 3PH, UK<i>ACBD3</i> overexpression has previously been found to correlate with worse prognosis for breast cancer patients and, as an incredibly diverse protein in both function and cellular localisation, ACBD3 may have a larger role in breast cancer than previously thought. This study further investigated ACBD3′s role in breast cancer. Bioinformatic databases were queried to characterise <i>ACBD3</i> expression and mutation in breast cancer and to investigate how overexpression affects breast cancer patient outcomes. Immunohistochemistry was carried out to examine ACBD3 location within cells and tissue structures. <i>ACBD3</i> was more highly expressed in breast cancer than in any other cancer or matched normal tissue, and expression over the median level resulted in reduced relapse-free, overall, and distant metastasis-free survival for breast cancer patients as a whole, with some differences observed between subtypes. IHC analysis found that ACBD3 levels varied based on hormone receptor status, indicating that ACBD3 could be a candidate biomarker for poor patient prognosis in breast cancer and may possibly be a biomarker for ER signal reprogramming of precancerous breast tissue.https://www.mdpi.com/1422-0067/23/16/8881ACBD3breast cancerchromosome 1qpatient outcomes
spellingShingle Jack Houghton-Gisby
Rachel Kerslake
Emmanouil Karteris
Kefah Mokbel
Amanda J. Harvey
ACBD3 Bioinformatic Analysis and Protein Expression in Breast Cancer Cells
International Journal of Molecular Sciences
ACBD3
breast cancer
chromosome 1q
patient outcomes
title ACBD3 Bioinformatic Analysis and Protein Expression in Breast Cancer Cells
title_full ACBD3 Bioinformatic Analysis and Protein Expression in Breast Cancer Cells
title_fullStr ACBD3 Bioinformatic Analysis and Protein Expression in Breast Cancer Cells
title_full_unstemmed ACBD3 Bioinformatic Analysis and Protein Expression in Breast Cancer Cells
title_short ACBD3 Bioinformatic Analysis and Protein Expression in Breast Cancer Cells
title_sort acbd3 bioinformatic analysis and protein expression in breast cancer cells
topic ACBD3
breast cancer
chromosome 1q
patient outcomes
url https://www.mdpi.com/1422-0067/23/16/8881
work_keys_str_mv AT jackhoughtongisby acbd3bioinformaticanalysisandproteinexpressioninbreastcancercells
AT rachelkerslake acbd3bioinformaticanalysisandproteinexpressioninbreastcancercells
AT emmanouilkarteris acbd3bioinformaticanalysisandproteinexpressioninbreastcancercells
AT kefahmokbel acbd3bioinformaticanalysisandproteinexpressioninbreastcancercells
AT amandajharvey acbd3bioinformaticanalysisandproteinexpressioninbreastcancercells